Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease.

Source:http://linkedlifedata.com/resource/pubmed/id/16432094

Arch. Intern. Med. 2006 Jan 23 166 2 231-3

Download in:

View as

Triples

General Info

PMID
16432094